Home › Non-Small Cell Lung Cancer › California › Santa Barbara
Non-Small Cell Lung Cancer clinical trials in Santa Barbara, CA
5 studies for Non-Small Cell Lung Cancer are looking for participants at sites in and around Santa Barbara (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RecruitingPhase 1
- Exelixis Clinical Site #59, Santa Barbara
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
RecruitingPhase 3
- Sansum Clinic, Santa Barbara
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Sansum Clinic, Santa Barbara
- Sansum Clinic, Solvang · 28 mi away
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RecruitingPhase 2
- Sansum Clinic, Santa Barbara
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RecruitingPhase 1/2
- USOR Sansum Clinic, Santa Barbara
Non-Small Cell Lung Cancer trials in other cities
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Other studies in Santa Barbara
- Cancer (all types)7 studies
- Breast Cancer6 studies
- Ovarian Cancer5 studies
- Urothelial (Transitional Cell) Carcinoma4 studies
- Prostate Cancer3 studies
- Type 2 Diabetes3 studies
- Pulmonary Hypertension3 studies
- Pulmonary Arterial Hypertension3 studies
- Endometrial Cancer3 studies
- Bladder Cancer3 studies
- Metastatic Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.